Tissue Regenix Group Share Price | |
---|---|
Price | 65.00 |
Bid | 63.00 |
Ask | 67.00 |
Change | 0.00 (0.00%) |
Volume | 5,062 |
Open | 65.00 |
High | 65.00 |
Low | 65.00 |
Prev. Close | 65.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 70.57m |
Market Capitalisation | £45.87m |
Market Size | 2,000 |
52 Week High | 71.50 |
52 Week High Date | 26-Feb-2024 |
52 Week Low | 49.00 |
52 Week Low Date | 03-Jul-2023 |
# Trades | 4 |
---|---|
Vol. Sold | 3,382 |
Sold Value | £2.15k |
Vol. Bought | 1,680 |
Bought Value | £1.13k |
PE Ratio | -34.05664 |
Earnings | -1.908585 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
21-Jun-24 | 15:44:05 | 64.00 | 500 | Sell* | 63.00 | 67.00 | 320.00 | O Ordinary |
21-Jun-24 | 10:31:23 | 64.00 | 500 | Sell* | 63.00 | 67.00 | 320.00 | O Ordinary |
21-Jun-24 | 08:51:32 | 67.00 | 1,680 | Buy* | 63.00 | 67.00 | 1,126 | O Ordinary |
21-Jun-24 | 08:14:55 | 63.20 | 2,382 | Sell* | 63.00 | 67.00 | 1,505 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
18-Jun-24 | 18-Jun-24 | Exercise of Option | Daniel Lee held the position of CEO at the time of this trade.Daniel Lee | 1.00 | GBX | 283,216 | 370,124 |
18-Jun-24 | 18-Jun-24 | Exercise of Option | David Cocke held the position of CFO at the time of this trade.David Cocke | 1.00 | GBX | 146,491 | 217,697 |
15-Sep-23 | 15-Sep-23 | Buy | Brian Phillips held the position of Independent Non-Executive Director at the time of this trade.Brian Phillips | 54.00 | GBX | 6,773 | 160,001 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.57 | GBX | 500,000 | 7,120,570 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.56 | GBX | 928,570 | 7,120,570 |
Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products.